Growing Saliva Collection Devices Market Owing to Rising Adoption of Home Testing Kits

The global saliva collection devices market is witnessing significant growth attributed to the growing prevalence of chronic diseases such as cancer and rising adoption of home testing kits for accurate disease diagnosis. The saliva collection devices market involves products used for saliva collection during various diagnostic tests performed to screen various diseases. Saliva collection devices help in non-invasive sample collection for further laboratory analysis. Saliva collection devices provide easier, safer, and cost-effective sample collection opportunities to patients compared to traditional blood collection methods.

The Global saliva collection devices market is estimated to be valued at US$ 342.46 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the saliva collection devices market are IBM Corporation, Oracle Corporation, Cerner Corporation, InterSystems Corporation, Allscripts Healthcare Solutions, Red Hat, Inc. (acquired by IBM), Microsoft Corporation, GE Healthcare, Infor, Inc., Epic Systems Corporation, TIBCO Software Inc., McKesson Corporation, Dell Technologies, Informatica Corporation, Ascom Holding AG. The growing demand for accurate disease diagnosis coupled with rising adoption of home testing kits are fueling the growth of the saliva collection devices market. Technological advancements in saliva collection devices such as automated collection systems and integrated diagnostic platforms are further propelling the market growth.

Market Trends

The increasing popularity of direct-to-consumer genetic testing is one of the major trends witnessed in the Saliva Collection Devices Market Size. Direct-to-consumer genetic testing allows people to order genetic testing kits online and receive results privately without having to visit a physician. Another major trend is the growth in self-collected saliva testing. Self-collected saliva samples are easy-to-collect, non-invasive samples and enable remote sample collection. This reduces health risks associated with in-person visits to clinics during the pandemic.

Market Opportunities

The rising focus on precision medicine and personalized healthcare presents significant opportunities for players in the saliva collection devices market. Precision medicine involves tailoring medical treatment to an individual patient's characteristics, lifestyle, and genetic profile. It allows targeting disease prevention and treatment methods based on an individual's molecular diagnosis. Another key opportunity is the increasing adoption of saliva testing in prenatal screening and non-invasive prenatal testing (NIPT). Saliva-based NIPT helps detect fetal chromosomal abnormalities non-invasively using a saliva sample from the pregnant woman.

Impact of COVID-19 on Saliva Collection Devices Market Growth

The COVID-19 pandemic has significantly impacted the growth of the saliva collection devices market. During the initial phase of the pandemic, the demand for saliva collection devices witnessed a sharp surge as saliva testing emerged as a promising alternative to nasal and throat swabs for COVID-19 diagnosis. However, as the pandemic spread worldwide, supply chain disruptions affected the production and distribution of saliva collection devices. With lockdowns restricting movement, transporting raw materials and finished products became challenging.

Additionally, priorities shifted to equip healthcare systems for critical care. Resources that would have gone into expanding saliva testing capacity were diverted. As a result, the market experienced short-term decline in 2020. However, mass vaccination drives and easing of lockdowns worldwide have enabled a restart of economic activities from 2021. Manufacturers are optimizing production to meet the growing demand for cost-effective, non-invasive COVID-19 and other infectious disease testing. Governments and private organizations are also supporting expansion of saliva-based testing infrastructure. This is expected to drive double-digit growth of the market in the forecast period. continuous innovations to develop high-quality, affordable collection devices will be crucial for business resilience and capturing opportunities in the post-COVID landscape.

Geographical Regions with High Concentration of Saliva Collection Devices Market in Terms of Value

North America holds the largest share of the overall saliva collection devices market in terms of value. This can be attributed to factors such as presence of major market players, favorable reimbursement policies, and widespread awareness about non-invasive testing benefits. The United States accounts for the bulk of the regional market owing to a well-established healthcare system and active government support for expanding COVID-19 testing infrastructure using saliva-based methods. Gradually increasing adoption of digital health technologies is also supporting the regional market growth.

Fastest Growing Region for Saliva Collection Devices Market

Asia Pacific is poised to be the fastest growing region for the saliva collection devices market during the forecast period. This owes to improving healthcare infrastructure, rising medical expenditures, increasing focus on infectious disease control, growing geriatric population susceptible to chronic illnesses in China and India. Governments are prioritizing investments to ramp up testing capacities. Local manufacturers are strengthening RD to address the massive unmet need. Favorable regulatory guidelines and expansion of global players into emerging Asia Pacific markets will further fuel the growth.